Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational discovery platform-ProMIS and Collective Coordinates-to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product candidates are PMN310, PMN267, and PMN442. The PMN310 is a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 product candidate targeting ALS. PMN442 is a drug candidate being developed for MSA designed to selectively target and protect against pathogenic a-syn species.


NDAQ:PMN - Post by User

Comment by DavidKingCanadaon Mar 10, 2022 4:30pm
128 Views
Post# 34504426

RE:Insider Trading

RE:Insider Trading

For those that have a few brain cells left, look at the following FACTUAL DATA;

8 out of 10 times there is a Press Release, the DAY BEFORE their is an incredible amount of NEGATIVE Volume and the next Day their is some Stupid PR that increases the SP by a few Cents and then back down again.

For those of you who still disagree then explain to me why this happens everytime and why Gene the CEO is getting away with this!

Now we have some college grad named Kevin who came in like a Vulture and accused everyone of False Information and has now VANISHED! 

This is a Fraud and the Boston Group has found a LOOP HOLE and people like M101 keep stating this but no one cares!

I respect M101 for her Balls but not anything else! 

<< Previous
Bullboard Posts
Next >>